Cassava Sciences (SAVA)
(Delayed Data from NSDQ)
$2.18 USD
-0.01 (-0.46%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $2.18 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Market Cap
As of the previous market close, Cassava Sciences, Inc. has a market cap of $105.79M, which represents its share price of $2.19 multiplied by its outstanding shares number of 48.31M. As a small-cap company, SAVA's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
SAVA 2.18 -0.01(-0.46%)
Will SAVA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SAVA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SAVA
Down -39.52% in 4 Weeks, Here's Why Cassava Sciences (SAVA) Looks Ripe for a Turnaround
Is the Future Bleak for SAVA Stock Following Another Setback?
SAVA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Biotech Stock Roundup: SAVA Dives on Setback, ALNY Up on Update & More
SAVA Stock Down as Alzheimer's Drug Fails in Second Late-Stage Study
Cassava Sciences (SAVA) Upgraded to Buy: What Does It Mean for the Stock?
Other News for SAVA
Cassava Sciences (SAVA) Appoints New Chief Medical Officer
Cassava Sciences taps Joseph Hulihan as chief medical officer
Cassava Sciences Appoints Dr. Joseph Hulihan as Chief Medical Officer | SAVA Stock News
Cassava Sciences appoints Hulihan as Chief Medical Officer
Cassava Sciences (SAVA) Reveals Positive Study Results for Epilepsy Treatment